These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2113388

  • 1. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

  • 2. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S, Herregodts P, Deleu D, Devrieze A, De Klippel N, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
    [Abstract] [Full Text] [Related]

  • 3. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-dopa.
    Brannan T, Knott P, Kaufmann H, Leung L, Yahr M.
    J Neural Transm; 1989 Sep; 75(2):149-57. PubMed ID: 2918307
    [Abstract] [Full Text] [Related]

  • 4. Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: an in vivo study.
    Brannan T, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1993 Sep; 6(1):35-44. PubMed ID: 7692872
    [Abstract] [Full Text] [Related]

  • 5. Preservation of dopamine release in the denervated striatum.
    Altar CA, Marien MR.
    Neurosci Lett; 1989 Jan 30; 96(3):329-34. PubMed ID: 2497410
    [Abstract] [Full Text] [Related]

  • 6. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K, Tanaka H, Maeda T, Tomiyama M, Suda T, Matsunaga M.
    J Neurochem; 2000 Jan 30; 74(1):263-9. PubMed ID: 10617128
    [Abstract] [Full Text] [Related]

  • 7. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK.
    Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002
    [Abstract] [Full Text] [Related]

  • 8. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K, Dluzen DE.
    J Neural Transm (Vienna); 1996 Oct 04; 103(11):1295-305. PubMed ID: 9013416
    [Abstract] [Full Text] [Related]

  • 9. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 04; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 10. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
    Robinson TE, Whishaw IQ.
    Brain Res; 1988 May 31; 450(1-2):209-24. PubMed ID: 3135914
    [Abstract] [Full Text] [Related]

  • 11. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
    Hefti F, Enz A, Melamed E.
    Neuropharmacology; 1985 Jan 31; 24(1):19-23. PubMed ID: 2858830
    [Abstract] [Full Text] [Related]

  • 12. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 31; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat.
    Orosz D, Bennett JP.
    Exp Neurol; 1992 Mar 31; 115(3):388-93. PubMed ID: 1537396
    [Abstract] [Full Text] [Related]

  • 14. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA, Rose S, Jenner P.
    Eur J Neurosci; 2001 Jan 31; 13(1):162-70. PubMed ID: 11135014
    [Abstract] [Full Text] [Related]

  • 15. The site of dopamine formation in rat striatum after L-dopa administration.
    Hefti F, Melamed E, Wurtman RJ.
    J Pharmacol Exp Ther; 1981 Apr 31; 217(1):189-97. PubMed ID: 7205652
    [Abstract] [Full Text] [Related]

  • 16. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep 31; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 17. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.
    Zetterström T, Brundin P, Gage FH, Sharp T, Isacson O, Dunnett SB, Ungerstedt U, Björklund A.
    Brain Res; 1986 Jan 08; 362(2):344-9. PubMed ID: 2417666
    [Abstract] [Full Text] [Related]

  • 18. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
    Brannan T, Martínez-Tica J, Yahr MD.
    Neurology; 1992 Mar 08; 42(3 Pt 1):683-5. PubMed ID: 1549240
    [Abstract] [Full Text] [Related]

  • 19. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T, Knott P, Kaufmann H, Yahr M.
    Adv Neurol; 1990 Mar 08; 53():75-81. PubMed ID: 2173378
    [No Abstract] [Full Text] [Related]

  • 20. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec 08; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.